L-NMMA acetate
CAS No. 53308-83-1
L-NMMA acetate( Tilarginine acetate | Methylarginine acetate )
Catalog No. M26734 CAS No. 53308-83-1
L-NMMA acetate is an inhibitor of nitric oxide synthase of all NOS isoforms (i.e. NOS1, NOS2, and NOS3).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 98 | In Stock |
|
| 25MG | 165 | In Stock |
|
| 50MG | 245 | In Stock |
|
| 100MG | 357 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL-NMMA acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-NMMA acetate is an inhibitor of nitric oxide synthase of all NOS isoforms (i.e. NOS1, NOS2, and NOS3).
-
DescriptionL-NMMA acetate is an inhibitor of nitric oxide synthase of all NOS isoforms (i.e. NOS1, NOS2, and NOS3). The Ki values are 0.18, 0.4, and 6 μM for nNOS, eNOS, and iNOS, respectively.(In Vitro):L-NMMA acetate inhibits vasodilator responses to the endothelium-dependent vasodilator ACh but not to the endothelium-independent NP. L-NMMA acetate does not affect isoprenaline-induced relaxation . The inhibitory effect of L-NMMA acetate is unchanged by previous incubation with D-arginine while it is prevented by L-arginine. L-NMMA acetate, starting from 100 μM, produces a concentration-dependent inhibition of the evoked relaxations (2Hz); maximal inhibition at 1 mM averaged about 35%. The Superfusion of L-NMMA acetate decreases arteriolar diameter and causes dose-dependent increases in arteriolar tone. The onset of action of L-NMMA acetate is nearly immediate. NE induced dose-related vasoconstriction that is significantly potentiated by L-NMMA acetate .
-
In VitroL-NMMA, starting from 100 μM, produces a concentration-dependent inhibition of the evoked relaxations (2Hz); maximal inhibition at 1 mM averaged about 35%. The inhibitory effect of L-NMMA is unchanged by previous incubation with D-arginine while it is prevented by L-arginine (L-Arg). L-NMMA does not affect isoprenaline-induced relaxation. Superfusion of L-NMMA reduces arteriolar diameter and causes dose-dependent increases in arteriolar tone. The onset of action of L-NMMA is nearly immediate. L-NMMA inhibits vasodilator responses to the endothelium-dependent vasodilator ACh but not to the endothelium-independent NP. NE induced dose-related vasoconstriction that is significantly potentiated by L-NMMA.
-
In Vivo——
-
SynonymsTilarginine acetate | Methylarginine acetate
-
PathwayImmunology/Inflammation
-
TargetNOS
-
RecptorBax| Caspase-3| IAP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53308-83-1
-
Formula Weight248.283
-
Molecular FormulaC9H20N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 50 mg/mL (201.39 mM)*)
-
SMILESCC(O)=O.CNC(=N)NCCC[C@H](N)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yao Z, et al. Synergistic effect of Se-methylselenocysteine and vitamin E in ameliorating the acute ethanol-induced oxidative damage in rat. J Trace Elem Med Biol. 2015 Jan;29:182-7.
molnova catalog
related products
-
EX-A5758
EX-A5758 is a novel putative small molecule nNOS-NOS1AP inhibitor, suppressing inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.
-
GW274150
GW274150 is a potent and highly selective inhibitor of iNOS with IC50 of 1.4 uM,
-
1400W dihydrochlorid...
1400 W is a highly potent and selective inhibitor of inducible NOS2 (iNOS).
Cart
sales@molnova.com